RESEARCH PAPER ANALYSIS
Multicenter prospective phase II study of decitabine priming with low-dose idarubicin, cytarabine, and G-CSF in children with refractory or relapsed acute myeloid leukemia.
AI interpretation is pending for this paper.
Open original publication →EXECUTIVE SUMMARY
What the AI sees
Not AI summarized yet.
WHY IT MATTERS
Research significance
Pending deeper interpretation.
ABSTRACT
Source abstract
No standard salvage regimen exists for relapsed/refractory (R/R) pediatric AML. In this prospective, multicenter Phase II trial, 101 evaluable patients (.
SUPPORTING PAPER SET
32 more papers to review
1
Comparison of Phenol Application and Endoscopic Pilonidal Sinus Treatment in Pediatric Pilonidal Sinus Disease.
Pediatrics international : official journal of the Japan Pediatric Society
63.74
2
Unfinished Business and Experiences of Bereaved Families of Patients with Cancer: A Cross-Sectional Survey.
Palliative medicine reports
61.0
3
The 21st International ``Ponte di Legno'' Childhood Acute Lymphoblastic Leukemia Workshop Report: Progress and Emerging Opportunities.
Clinical lymphoma, myeloma & leukemia
49.0
4
Acute Leukemia During the First Six Months of Life: A Population-Based Analysis of Survival by Leukemia Type.
Clinical lymphoma, myeloma & leukemia
64.12
5
Pediatric orbital solitary fibrous tumor/hemangiopericytoma presenting with isolated eyelid edema: a case report.
Frontiers in pediatrics
53.1
6
Malignancies in patients with inborn errors of immunity: insights from 20-years of clinical experience in Qatar.
Frontiers in immunology
68.6
7
Precision medicine and parental experience: a longitudinal study of psychosocial responses to germline genomic results in pediatric oncology.
Frontiers in medicine
67.36
8
Cytokine-augmented risk stratification for six-month incident nephritis in children with IgA vasculitis.
Frontiers in pediatrics
58.5
9
Time-bounded uncertainty in childhood cancer survivorship: a psycho-oncology perspective on result communication.
Frontiers in psychology
57.0
10
"From misdiagnosis to precision medicine: strengthening pediatric neuro-oncology care in LMICs toward equitable pLGG outcomes".
Frontiers in oncology
75.5
11
Practical Guidance on Initiating and Switching Targeted Immunotherapies in Generalised Myasthenia Gravis: A German-Austrian Expert Opinion Paper.
European journal of neurology
66.4
12
Technical Considerations for Robotic Pediatric Lobectomy.
Annals of thoracic surgery short reports
54.0
13
Kaposi Sarcoma-Associated Herpesvirus Is Not Detected in Osteosarcoma From KSHV-Endemic African Countries and the Non-Endemic United States Populations.
Journal of medical virology
59.5
14
ELISA (Embedding-Linked Interactive Single-cell Agent): an interpretable hybrid generative Artificial Intelligence agent for expression-grounded discovery in single-cell genomics.
Briefings in bioinformatics
48.5
15
Thyroid Cancer in the Modern Era: From Molecular Landscape and Multimodal Diagnostics to Integrative Traditional Chinese Medicine-A Comprehensive Review.
Cancer management and research
90.6
16
Presumed left atrial myxoma presenting with seizures, massive stroke, and systemic embolization in an adolescent: a case report.
International journal of emergency medicine
49.0
17
Ewing's Sarcoma in Adults: A Predictive Nomogram and Survival Analysis of a Cohort of 937 Patients.
Journal of surgical oncology
73.92
18
Comments on "Initial Cerebrospinal Fluid Blast Clearance Rate in Pediatric B-Lymphoblastic Leukemia Is Associated With Overall Survival".
Journal of pediatric hematology/oncology
49.12
19
Impact of Number of Lymph Nodes Sampled and Density of Positive Nodes on Outcomes Among Over 2000 Patients With Stage I to III Favorable Histology Wilms Tumor Enrolled on AREN03B2: A Children's Oncology Group Renal Tumor Study.
Annals of surgery
70.5
20
Prognostic impact of risk organ involvement and metabolic parameters assessed by staging 18F-FDG PET/CT in pediatric Langerhans cell histiocytosis.
Nuclear medicine communications
63.3
21
Prognostic value of plasma thymus- and activationregulated chemokine levels after the second cycle of chemotherapy in pediatric Hodgkin lymphoma.
Haematologica
55.44
22
Germline lymphoma-predisposing variants: impact on age of cancer diagnosis and survival in pediatric patients.
Haematologica
51.12
23
Excess mortality convergence after paediatric allogeneic transplantation: a caveat for the right to be forgotten. Comment on: "Decreasing excess mortality after allogeneic stem cell transplantation for acute leukemia".
Haematologica
49.5
24
EARLY DISCONTINUATION OF ANTIBIOTICS IN PEDIATRIC PATIENTS WITH LOW- AND HIGH-RISK FEBRILE NEUTROPENIA: A SINGLE-CENTRE EXPERIENCE.
Journal of the Pediatric Infectious Diseases Society
68.4
25
Comment on "How I Approach Anxiety in Children and Teens with Cancer".
Pediatric blood & cancer
47.5
26
Progressive Tracheal Injury Following Tumor Regression in a Child With T-Cell Lymphoblastic Lymphoma.
Pediatric blood & cancer
28.5
27
Very Late Relapse of Acute Myeloid Leukemia With a Rare HNRNPH1::MLLT10 Fusion Following a Pediatric Myeloid Neoplasm: A Successful Venetoclax-Azacitidine Bridge to Hematopoietic Stem Cell Transplantation.
Pediatric blood & cancer
49.12
28
Interventions to Reduce Financial Toxicity of Childhood, Adolescent, and Young Adult Cancer Survivors: A Scoping Review.
Pediatric blood & cancer
61.32
29
ENCERT: A Multisite Phase 1 Trial Using Everolimus in Combination With Nelarabine, Cyclophosphamide, and Etoposide in Relapsed T-Cell Lymphoblastic Leukemia/Lymphoma.
Pediatric blood & cancer
87.42
30
Advanced Radiotherapy Across a Multi-Geography Referral Network for Children With Ewing Sarcoma and Rhabdomyosarcoma: Treatment Delivery and Early Outcomes-A Single-Centre Experience.
Pediatric blood & cancer
72.88
31
Genomic Characterization of ETV6::RUNX1-Positive Childhood B-ALL in a Chinese Cohort: Novel Fusion Partners, Co-Occurring Mutations, and Risk-Stratifying Biomarkers.
Pediatric blood & cancer
59.75
32
Diagnostic Yield of Brain MRI in Pediatric Short Stature: Hypothalamic-Pituitary Lesions and Incidental Findings in Real-World Practice.
Clinical endocrinology
67.3